Glenmark Pharmaceuticals Ltd

NSE: GLENMARK BSE: 532296

₹2209.60

(1.52%)

Wed, 17 Jun 2026, 05:23 pm

MTF 5xInvest in Glenmark Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)61478.86

PE Ratio45.80

Dividend0.23

Health Technology

Pharmaceuticals: Major

24.5K

Glenmark Pharmaceuticals News

Glenmark Pharma Launches Winlevi® Cream Across Europe

Glenmark Pharmaceuticals launches Winlevi® Cream for acne treatment in major European markets, marking its first New Chemical Entity launch in Europe and expanding its dermatology portfolio.

11 Jun 2026

companies

Glenmark targets 13-15% revenue CAGR

Glenmark outlines strategy for FY26-30, focusing on branded growth and innovation to drive long-term value.

09 Jun 2026

companies

Glenmark launches Lacosamide Injection in US market

Glenmark Pharmaceuticals Inc. launched Lacosamide Injection USP in the US. The product is a therapeutic equivalent to UCB's Vimpat Injection.

05 Jun 2026

companies

Glenmark Pharma Eyes Respiratory Growth in FY27

Glenmark Pharmaceuticals targets respiratory product growth in FY27, with Winlevi® securing EU approval and Aumolertinib's initial launch anticipated in H2 FY27.

30 May 2026

companies

Glenmark appoints new Company Secretary

Glenmark Pharmaceuticals appointed Ms. Rashmi Khandelwal as Company Secretary & Compliance Officer effective May 30, 2026. Mr. Harish Kuber retired early from the role on May 29, 2026.

29 May 2026

companies

Showing 1–5 of 78

Rows per page:

Market Current News

S&P 500 Edges Lower at Market Open

The S&P 500 slipped 2.39 points, or 0.03%, to 7,551.90 shortly after the market open, reflecting a marginal decline in early trading.

16 Jun 2026

global

FERMENTA BIOTECH LIMITED

Fermenta Biotech seeks NSE listing

Fermenta Biotech applied to NSE on June 16, 2026, for direct listing of equity shares to enable trading on the exchange platform.

16 Jun 2026

ipo

Avience Biomedicals IPO opens June 18

Avience Biomedicals Limited plans an SME IPO to fund ₹15.96 crore capex. Revenue surged 88.81% in FY25, but cash flow turned negative.

16 Jun 2026

ipo

Riyaasat Lifestyle files DRHP for SME IPO

Riyaasat Lifestyle Limited filed its Draft Red Herring Prospectus for an SME IPO to raise funds for expansion. The ethnic wear company reported revenue of ₹27.87 Cr for the 10 months ended Jan 2026.

16 Jun 2026

ipo

Anubhav Plast files DRHP for SME IPO

Anubhav Plast Limited filed its DRHP for an SME IPO to raise ₹15.95 crore. Net profit surged 8x to ₹6 crore in FY25.

16 Jun 2026

ipo

Showing 1–5 of 93889

Rows per page: